basiliximab
Drug Details
- Generic Name
- basiliximab
- Brand Names
- Simulect
- Application Number
- BLA103764
- Sponsor
- Novartis Pharmaceuticals Corporation
- NDC Codes
- 4
- Dosage Forms
- INJECTION, POWDER, FOR SOLUTION, LIQUID
- Routes
- INTRAVENOUS
- Active Ingredients
- BASILIXIMAB
Indications and Usage
INDICATIONS AND USAGE Simulect ® (basiliximab) is indicated for the prophylaxis of acute organ rejection in patients receiving renal transplantation when used as part of an immunosuppressive regimen that includes cyclosporine, USP (MODIFIED), and corticosteroids. The efficacy of Simulect for the prophylaxis of acute rejection in recipients of other solid organ allografts has not been demonstrated.
Warnings
WARNINGS. See Boxed WARNING.